Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies Journal Article


Authors: Griffiths, G. L.; Govindan, S. V.; Sgouros, G.; Ong, G. L.; Goldenberg, D. M.; Mattes, M. J.
Article Title: Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies
Abstract: We investigated the in vitro cytotoxic potential of Auger electron- emitting radionuclides delivered to the cytoplasm or, more specifically, to lysosomes, via antibodies. The antibody (Ab) used was LLI, which is specific for CD74, an epitope of the major histocompatibility complex (MHC) class II antigen invariant chain, Ii, present on the cell surface. It is taken up in large amounts, approximately 107 Ab molecules per cell per day, and delivered to lysosomes. The radioisotopes tested included 111In, 99mTc and 125I. With sufficient specific activity, approximately 10 mCi/mg Ab, all of these isotopes were potent cytotoxic agents, 125I was active only if a 'residualizing' form was used, meaning a form that is trapped within cells after catabolism of the Ab to which it was conjugated (conventional oxidative iodination produces a non-residualizing label). The conjugates of 111In and 99mTc used are known to be residualizing. One hundred percent cell kill in vitro was obtained with 111In and 125I, under conditions in which a non-reactive control Ab; conjugated in the same way, produced no significant toxicity. 99mTc was also potent and specific, but appeared somewhat less active than the other isotopes under the conditions evaluated. Although few Abs are accreted by cells at the same rate as LLI, it may be possible to use other Abs to deliver similar amounts of radioactivity, if Abs with higher specific activity can be produced. Such conjugated radioisotopes may be useful for attacking tumor cells in vivo, particularly for single cells or micrometastases.
Keywords: controlled study; human cell; technetium 99m; cell survival; cytotoxicity; in vitro study; tumor cells, cultured; dose-response relationship, radiation; lymphoma, b-cell; indium radioisotopes; kinetics; antigens, neoplasm; iodine 125; iodine radioisotopes; antibodies; radioisotope; histocompatibility antigens class ii; major histocompatibility complex; radioimmunotherapy; indium 111; electrons; antibody; radioisotope therapy; lysosome; radioisotope distribution; gamma rays; lymphoma cell line; technetium; antigens, differentiation, b-lymphocyte; auger electron spectroscopy; humans; human; priority journal; article
Journal Title: International Journal of Cancer
Volume: 81
Issue: 6
ISSN: 0020-7136
Publisher: John Wiley & Sons  
Date Published: 1999-06-11
Start Page: 985
End Page: 992
Language: English
DOI: 10.1002/(sici)1097-0215(19990611)81:6<985::aid-ijc23>3.0.co;2-w
PUBMED: 10362149
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 16 August 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. George Sgouros
    146 Sgouros